Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning

Movement Disorders

Volumn 25, Issue 11, 2010, Pages 1612-1618

  Reedeker, Nanda ^a   Van Der Mast, Rose C ^a   Giltay, Erik J ^a   Van Duijn, Erik ^a,b   Roos, Raymond A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Center for Mental Health Care Delfland   (Netherlands)

Author keywords

Apathy; Cognition; Global functioning; Huntington's disease; Hypokinesia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

APATHY; ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC INTERVIEW SCHEDULE; DISEASE SEVERITY; FEMALE; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; HYPOKINESIA; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY ANALYSIS; SOCIOECONOMICS;

ADULT; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; EXECUTIVE FUNCTION; FEMALE; HUMANS; HUNTINGTON DISEASE; HYPOKINESIA; LINEAR MODELS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; STATISTICS AS TOPIC;

EID: 77955777531     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23136     Document Type: Article

References (27)

1. Walker FO. Huntington's disease. Lancet 2007;369:218-228.
2. Bates G. PHLJ. Huntington's Disease, Third ed. Oxford University Press; 2002.
3. Maat-Kievit A, Losekoot M, Zwinderman K, et al. Predictability of age at onset in Huntington disease in the Dutch population. Medicine 2002;81:251-259.
4. Van Vugt JP, Van Hilten BJ, Roos RA. Hypokinesia in Huntington's disease. Mov Disord 1996;11:384-388.
5. Penney JB, Young AB, Shoulson I, et al. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 1990;5:93-99.
6. Van Duijn E, Kingma EM, Timman R, et al. Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative firstdegree relatives. J Clin Psychiatry 2008;69:1804-1810.
7. Rosenblatt A, Leroi I. Neuropsychiatry of Huntington's disease and other basal ganglia disorders. Psychosomatics 2000;41:24-30.
8. Van DE, Kingma EM, Van Der Mast RC. Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci 2007;19:441-448.
9. Baudic S, Maison P, Dolbeau G, Boisse MF, Bartolomeo P, Dalla BG, et al. Cognitive impairment related to apathy in early Huntington's disease. Dement Geriatr Cogn Disord 2006;21:316-321.
10. Thompson JC, Snowden JS, Craufurd D, Neary D. Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. J Neuropsychiatry Clin Neurosci 2002;14:37-43.
11. Rothlind JC, Bylsma FW, Peyser C, Folstein SE, Brandt J. Cognitive and motor correlates of everyday functioning in early Huntington's disease. J Nerv Ment Dis 1993;181:194-199.
12. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
13. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 2008;79:874-880.
14. World Health Organization. Composite International Diagnostic Interview. World Health Organization, 1997.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth ed. Washington DC: American Psychiatric Association; 2000.
16. Starkstein SE, Fedoroff JP, Price TR, Leiguarda R, Robinson RG. Apathy following cerebrovascular lesions. Stroke 1993; 24:1625-1630.
17. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:134-139.
18. Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D. Dissociating apathy and depression in Parkinson disease. Neurology 2006;67:33-38.
19. Folstein MF, Folstein SE, Mchugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Hodges JR. Cognitive Assessment Clinicians; 2009.
21. Smith A. The symbol digit modalities test: a neuropsychologic test for economic screening of learning and other cerebral disorders. Learn Disord 1968;3:83-91.
22. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
23. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979;29:1-3.
24. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol 1998;55:1313-1319.
25. Kulisevsky J, Litvan I, Berthier ML, Pascual-Sedano B, Paulsen JS, Cummings JL. Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders. Movement Disord 2001;16: 1098-1104.
26. Sanchez-Pernaute R, Kunig G, Del Barrio AA, De Yebenes JG, Vontobel P, Leenders KL. Bradykinesia in early Huntington's disease. Neurology 2000;54:119-125.
27. Rosenblatt A, Abbott MH, Gourley LM, et al. Predictors of neuropathological severity in 100 patients with Huntington's disease. Ann Neurol 2003;54:488-493.